OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	70
	51
Abstracts	38
	28
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	26
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	24
PNS Abstracts 2023	21
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	19
Prospective Evaluation of Machine‐Assisted Electrophysiologic and Online Clinical Diagnostic Support Tools in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	19
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	19
	18
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	18
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	17
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	16
Ofatumumab for treating autoimmune nodopathy	16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	14
Issue Information	14
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	12
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	12

Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
Issue Information	11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	11
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	10
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	10
Issue Information	10
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	10
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	10
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	10
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	9
Peter James Dyck: In Memoriam	9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	9
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	9
	8
Issue Information	8
	8
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	8
Issue Information	8
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
Issue Information	7
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
The autoimmune vulnerability of the node of Ranvier	6
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
	6
Issue Information	6
ABSTRACT	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
Impact of High‐Dose Tafamidis on Hereditary ATTR ( ATTRv ) Amyloidosis With Central Nervous System	5
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	5
	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
	5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4
Anxiety and depression in small fiber neuropathy	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Nonsystemic Vasculitic Neuropathy—A Brazilian Case Series	4
Issue Information	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Issue Information	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4